Skip to main content
Tech.euFundingExplorerBeta

Phlox Therapeutics

Phlox Therapeutics is developing Ribonucleic acid (RNA)-based gene therapies to treat cardiomyopathies, disorders that affect the heart muscle.

Phlox Therapeutics has raised €1.9M across 1 funding round from 5 investors, most recently a round in Nov 2024. Based in Naarden, Netherlands; active in Healthtech. Data as of 28 Oct 2026.

Naarden, Netherlandsphloxtherapeutics.com ↗
Healthtech
← All companies
Total raised
€1.9M
€1,900,000
Funding rounds
1
Investors
5
distinct backers
Active since
2024-11
latest 2024-11

Funding by year

EUR raised per year
Phlox Therapeutics — funding by year — interactive chart.
Data table
Phlox Therapeutics — funding by year
2024€1.9M

Signals

High confidence
Raise-next likelihood28
base rate 30% for Other
  • ▲ In typical raise window
  • ▼ Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2024-11-13Other€1.9MAmsterdam UMC Venture Holding,FIRST Fund,ROM Utrecht Region,syndicate,Utrecht Health Seed Fund (UHSF)View deal →

Investors

5
Amsterdam UMC Venture HoldingFIRST FundROM Utrecht RegionsyndicateUtrecht Health Seed Fund (UHSF)

Related news

Similar companies

same sector or country

Global coverage: FundingData